World Health Organization. Towards universal access. Scaling up priority HIV/AIDS interventions in the health sector, progress report, April 2007. [http://www.who.int/hiv/mediacentre/universal_access_progress_report_en.pdf]
PEPFAR five year HIV/AIDS plan. [http://www.pepfar.gov/85811.htm]
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000, 133: 21-30.
Article
CAS
PubMed
Google Scholar
Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA: Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA. 1997, 277: 1962-1969. 10.1001/jama.277.24.1962.
Article
CAS
PubMed
Google Scholar
García de Olalla P, Knobel H, Carmona A, Guelar A, López-Colomés JL, Caylà JA: Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Deficiency. 2002, 30: 105-110. 10.1097/00126334-200205010-00014.
Article
Google Scholar
Blower SM, Aschenbach AN, Gershengorn HB, Kahn JO: Predicting the unpredictable: Transmission of drug resistant HIV. Nat Med. 2001, 7: 1016-1020. 10.1038/nm0901-1016.
Article
CAS
PubMed
Google Scholar
Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, Reuter H, Ntwana N, Goemaere E: Outcomes after two years of providing ART in Khayelitsha, South Africa. AIDS. 2004, 18: 887-895. 10.1097/00002030-200404090-00006.
Article
PubMed
Google Scholar
Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, George E, Kenel-Pierre S, Wright PF, Gulick R, Johnson WD, Pape JW, Fitzgerald DW: Antiretroviral therapy in a thousand patients with AIDS in Haiti. NEJM. 2005, 353: 2325-34. 10.1056/NEJMoa051908.
Article
CAS
PubMed
Google Scholar
Bekker LG, Myer L, Orrell C, Lawn S, Wood R: Rapid scale-up of community-based HIV treatment service. Programme performance over 3 consecutive years in Guguletu, South Africa. S Afr Med J. 2006, 96 (4): 315-320.
PubMed
Google Scholar
Laurent C, Diakhaté N, Gueye NF, Touré MA, Sow PS, Faye MA, Gueye M, Lanièce I, Touré Kane C, Liégeois F, Vergne L, Mboup S, Badiane S, Ndoye I, Delaporte E: The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS. 2002, 16: 1363-70. 10.1097/00002030-200207050-00008.
Article
PubMed
Google Scholar
Macharia DK, Chang LW, Lule G, Owili DM, Tesfaledet G, Patel S, Silverstein DM, Ng'ang'a L, Bush T, De Cock KM, Weidle PJ: Antiretroviral therapy in the private sector of Nairobi, Kenya: a review of the experience of five physicians. AIDS. 2003, 17: 938-940. 10.1097/00002030-200304110-00028.
Article
PubMed
Google Scholar
Djomand G, Roels T, Ellerbrock T, Hanson D, Diomande F, Monga B, Maurice C, Nkengasong J, Konan-Koko R, Kadio A, Wiktor S, Lackritz E, Saba J, Chorba T: Virological and immunological outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire. AIDS. 2003, 17 (suppl 3): S5-15.
Article
PubMed
Google Scholar
Hofer CB, Schechter M, Harrison LH: Effectiveness of antiretroviral therapy among patients who attend public HIV clinics in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 2004, 36: 967-71. 10.1097/00126334-200408010-00011.
Article
PubMed
Google Scholar
Knobel H, Guelar A, Carmona A, Espona M, González A, López-Colomés JL, Saballs P, Gimeno JL, Díez A: Virological outcomes and predictors of virological failure of active antiretroviral therapy containing protease inhibitors. AIDS Patient Care STDs. 2001, 15: 193-9. 10.1089/10872910151133729.
Article
CAS
PubMed
Google Scholar
Kitchen CM, Kitchen SG, Dubin JA, Gottlieb MS: Initial virological and immunological response to highly active antiretroviral therapy predicts long-term clinical outcome. Clin Infect Dis. 2001, 33: 466-472. 10.1086/321900.
Article
CAS
PubMed
Google Scholar
Powderly WG, Saag MS, Chapman S, Yu G, Quart B, Clendeninn NJ: Predictors of optimal virological response to potent antiretroviral therapy. AIDS. 1999, 13: 1873-1880. 10.1097/00002030-199910010-00009.
Article
CAS
PubMed
Google Scholar
Phillips AN, Staszewski S, Weber R, Kirk O, Francioli P, Miller V, Vernazza P, Lundgren JD, Ledergerber B, Swiss HIV Cohort Study; Frakfurt HIV Clinic Cohort; EuroSIDA Study Group: HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA. 2001, 286: 2560-7. 10.1001/jama.286.20.2560.
Article
CAS
PubMed
Google Scholar
Bartlett JA, DeMasi R, Quinn J, Moxham C, Rousseau F: Overview of the effectiveness of triple combination therapy in antiretroviral-naïve HIV-1 infected adults. AIDS. 2001, 15: 1369-1377. 10.1097/00002030-200107270-00006.
Article
CAS
PubMed
Google Scholar
Charalambous S, Grant AD, Day JH, Pemba L, Chaisson RE, Kruger P, Martin D, Wood R, Brink B, Churchyard GJ: Establishing a workplace antiretroviral therapy programme in South Africa. AIDS Care. 2007, 19: 34-41. 10.1080/09500340600677872.
Article
CAS
PubMed
Google Scholar
WHO: Interim proposal for a WHO staging system for HIV infection and disease. Weekly Epidemiological Record. 1990, 65: 221-224.
Google Scholar
Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E: Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS. 2004, 18 (suppl 3): S27-S31. 10.1097/00002030-200406003-00006.
Article
PubMed
Google Scholar
The Antiretroviral Therapy in Lower Income Countries (ART-LINC) and ART Cohort Collaboration (ART-CC) groups: Mortality of HIV-1 infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006, 367: 817-824. 10.1016/S0140-6736(06)68337-2.
Article
Google Scholar
Lawn SD, Myer L, Orrell C, Bekker LG, Wood R: Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS. 2005, 19: 2141-2148.
Article
PubMed
Google Scholar
Moore RD, Keruly JC, Gebo KA, Lucas GM: An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002. J Acquir Immune Defic Syndr. 2005, 39: 195-198.
PubMed
Google Scholar
Charalambous S, Innes C, Muirhead D, Kumaranayake L, Fielding K, Pemba L, Hamilton R, Grant A, Churchyard GJ: Evaluation of a workplace HIV treatment programme in South Africa. AIDS. 2007, 21 (suppl 3): S73-S78. 10.1097/01.aids.0000279696.63438.aa.
Article
PubMed
Google Scholar
Rosen S, Fox MP, Gill CJ: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007, 4 (10): e298-10.1371/journal.pmed.0040298.
Article
PubMed
PubMed Central
Google Scholar
Lepri AC, Miller V, Phillips AN, Rabenau H, Sabin CA, Staszewski S: The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4–8 viral load. AIDS. 2001, 15: 47-54. 10.1097/00002030-200101050-00008.
Article
CAS
PubMed
Google Scholar
Smith CJ, Staszewski S, Sabin CA, Nelson M, Dauer B, Gute P, Johnson MA, Phillips AN, Gazzard B: Use of viral load measured after 4 weeks of highly active antiretroviral therapy to predict virologic outcome at 24 weeks for HIV-1-positive individuals. J Acquir Immune Defic Syndr. 2004, 37: 1155-1159. 10.1097/01.qai.0000135958.80919.e4.
Article
CAS
PubMed
Google Scholar
Department of Health, South Africa. Training manual – Operational plan for comprehensive HIV and AIDS care, management and treatment for South Africa. 2nd edition, January 2005. [http://www.doh.gov.za/docs/hivaids-progressrep.html]